Stock Events

Stock Events

NetraMark 

$0.67
7
+$0.04+6.46% Monday 16:28

Statistics

Day High
0.63
Day Low
0.63
52W High
1.26
52W Low
0.63
Volume
1,000
Avg. Volume
1,613
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-1,221.28%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
611,549.87Revenue
-7.47MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AINMF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a major player in the pharmaceutical industry, directly competing with NetraMark in drug development and personalized medicine.
Novartis
NVS
Mkt Cap237.61B
Novartis is involved in advanced pharmaceuticals and personalized healthcare solutions, overlapping with NetraMark's focus areas.
Merck
MRK
Mkt Cap214.76B
Merck operates in the pharmaceutical sector, focusing on innovative therapies that compete with NetraMark's offerings.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly is a leader in pharmaceuticals, particularly in areas that utilize AI for drug discovery, similar to NetraMark's approach.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline focuses on research in pharmaceuticals, competing with NetraMark in the development of new drugs and health solutions.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie works in biopharmaceuticals, directly competing with NetraMark in therapeutic areas and personalized medicine.
AMGEN
AMGN
Mkt Cap160.66B
Amgen specializes in biotechnological medicines, which aligns with NetraMark's focus on innovative healthcare solutions.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb is a major biopharma company, competing in the same space as NetraMark with a focus on serious diseases.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals focuses on genetic and biomarker-driven drug development, similar to NetraMark's AI-driven approach.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Vertex Pharmaceuticals is known for its scientific innovations in healthcare, competing with NetraMark in drug discovery and development.

About

NetraMark Holdings Inc. focuses on developing artificial intelligence and machine learning solutions for pharmaceutical and biotechnology companies in Canada. The company develops NetraAI, an interactive augmented intelligence platform; Netra Shatter; and Netra Health Atlas, a consulting service that helps to discover new drugs, repurpose existing drugs, and resurrect drugs that have failed clinical trials, as well as Nuro app that helps athletes to deal with mental performance. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was incorporated in 2019 and is headquartered in Toronto, Canada.
Show more...
CEO
Mr. George Achilleos
Country
CA
ISIN
CA64119M1059

Listings

OTC Link
US
AINMF
F
DE
PF0.F
TO
CA
AIAI.TO

0 Comments

Share your thoughts

FAQ

What is NetraMark stock price today?▼
The current price of AINMF is $0.67 USD — it has increased by +6.46% in the past 24 hours. Watch NetraMark stock price performance more closely on the chart.
What is NetraMark stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange NetraMark stocks are traded under the ticker AINMF.
Is NetraMark stock price growing?▼
AINMF stock has fallen by -0.33% compared to the previous week, the month change is a -11.75% fall, over the last year NetraMark has showed a -29.62% decrease.
What is NetraMark revenue for the last year?▼
NetraMark revenue for the last year amounts to 611,549.87 USD.
What is NetraMark net income for the last year?▼
AINMF net income for the last year is -7.47M USD.
In which sector is NetraMark located?▼
NetraMark operates in the Health Care sector.
When did NetraMark complete a stock split?▼
NetraMark has not had any recent stock splits.
Where is NetraMark headquartered?▼
NetraMark is headquartered in Toronto, CA.